Formed in 2011 by Christopher Watt and Samuel Thangiah, Life Science Integrates (LSI) brings together Senior Leaders from across the Life Sciences, including industry, academia, government and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.
Our purpose is to find novel and engaging ways to bring people together; to discuss, debate and uncover the strategic solutions to their industry’s challenges by creating environments that challenge traditional concepts and enable constructive debate around disruptive innovations, business models and supply chains to ensure that today’s ideas and concepts will become the effective therapies and diagnostics of the future. Ultimately helping to ensure that the Life Science Industry delivers the best possible outcomes for patients and carers.
Life Science Integrates has enabled the conversations that have helped shape our industry today and will set the direction for the future.
COP26 has brought into sharp focus the need to minimise our impact on the planet. This event will bring policymakers together with pharmaceutical companies, industry bodies and academia to discuss the implications of COP26 for the industry.
Bio Integrates Focuses on the biotech, start-up and emerging pharma sector addressing the needs of innovative companies that develop therapies of tomorrow.
MedTech Integrates Addresses the needs of the MedTech community to overcome the challenges needed to achieve a transformation of diagnostics and devices in healthcare.
PharmaTech Integrates will bring together all the parties to promote, educate and connect the sector to enhance technology adoption in the responsive manufacture of medicines both new and old.
Facilitating the translation of cutting-edge research and disruptive innovation into the adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
Bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
Enterprise virtual reality (VR) software provider Immerse has today announced its new partnership with DTG, a digital transformation company that delivers technology and solutions that enable clients to embrace the operational, cultural and financial benefits of digitalisation.
The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market.
While batch process chemistry remains the standard in the pharmaceutical industry, a clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. I
